Rx Industry Must Take Phase IV “Seriously,” Commissioner Tells PhRMA
Executive Summary
Pharmaceutical manufacturers need to step up their commitment to postmarketing surveillance and studies, FDA Commissioner McClellan told the Pharmaceutical Research & Manufacturers of America March 28 in Naples, Fla